Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Tjoapack doubles packaging capacity with completed Netherlands facility expansion

    Apr 25, 2022, 17:19 PM by
    Global pharmaceutical contract packaging organisation (CPO), Tjoapack has announced the completion of its expansion plans following a €10m+ plus investment at its Etten-Leur facility in the Netherlands.
    Full story
  • Rho Appoints Peter Schmidt, Ph.D., as SVP, Government Partnerships, Executive Committee Member

    Apr 25, 2022, 17:19 PM by
    Rho Appoints Peter Schmidt, Ph.D., as SVP, Government Partnerships, Executive Committee Member Former Vice Dean at East Carolina University’s Brody School of Medicine brings scientific and strategic expertise to lead the federally funded clinical research enterprise of this international CRO. Research Triangle Park, NC – April 19, 2022 – Rho, a global full-service contract research organization (CRO) with a proven track record of drug development success, has appointed Peter Schmidt, Ph.D., as Senior Vice President, Government Partnerships of Rho’s Federal Systems Division. For over 30 years, Rho has worked closely with NIH/NIAID and other federal departments on groundbreaking clinical trial and epidemiologic studies, including the LEAP peanut allergy study. “I am thrilled to welcome Dr. Schmidt to Rho," said Dr. Laura Helms Reece, CEO, Rho. “He is a preeminent neuroscientist and recognized leader across federal, commercial and academic arenas. His expertise in clinical research is remarkable, and his command of central nervous system, infectious disease, and other indications is a great fit with Rho’s focus in those areas. I am eager to work with Dr. Schmidt as he brings exciting strategic and scientific leadership to our federal business. His experience and judgment will be great additions to our Executive Committee.”
    Full story
  • Recipharm completes US biologics acquisitions

    Apr 25, 2022, 17:19 PM by
    Recipharm, a leading global contract development and manufacturing organisation (CDMO), today announces the closing of its acquisitions of advanced therapy CDMO Arranta Bio and virotherapy CDMO Vibalogics.
    Full story
  • Bora Pharmaceuticals to expand operations with $10m+ investment

    Apr 25, 2022, 17:19 PM by
    Full story
  • Huateng Pharma Develops COVID-19 Drug Paxlovid & Ensitrelvir Intermediates

    Apr 25, 2022, 17:19 PM by
    Huateng Pharma is a full-service Contract Development Manufacturing Organizations (CDMO) for pharmaceutical intermediates, including paxlovid and ensitrelvir intermediates.
    Full story
  • Global Single-Cell Analysis Market valued at USD 2.1 billion (2020), is growing at a healthy CAGR of 17.8% through the forecast period 2020-2025

    Apr 25, 2022, 17:19 PM by
    Medi-Tech Insights offers an interesting research report on Global Single-Cell Analysis Market. The market growth is likely to be driven by emerging life science and oncology research.
    Full story
  • Accelerating Peptide Drug Research with Creative Peptides’ Premade Peptide Library

    Apr 25, 2022, 17:19 PM by
    Creative Peptides constructed a versatile total peptide library with its proprietary peptide design platform to accelerate peptide drug research.
    Full story
  • BOC Sciences Unveils Comprehensive Custom Synthesis Services

    Apr 25, 2022, 17:19 PM by
    BOC Sciences unveils its comprehensive custom synthesis services for worldwide partners engaged in biopharmaceutical, chemical, and life science research.
    Full story
  • List Bio Raises $48.4 Million Series A for Global Scale-Up

    Apr 25, 2022, 17:19 PM by
    List Bio will use an $48.4 million Series A investment to build a large-scale manufacturing facility in Fishers, Indiana, USA
    Full story
  • Panthera Biopartners raises £10 million to accelerate its dedicated clinical trial site expansion across the UK and Western Europe

    Apr 25, 2022, 17:19 PM by
    Panthera Biopartners has secured £10 million of investment from BGF and Gresham House Ventures, the latter investing on behalf of the Baronsmead VCTs. This investment round will be used to fund further expansion in the UK and Western Europe.
    Full story
  • DNDi and BenevolentAI collaborate to accelerate life-saving drug discovery research in dengue

    Apr 25, 2022, 17:19 PM by
    Full story
  • Scitara™ Digital Lab Exchange DLX™ Gains ISO Certification and Advances the Modern Lab with the Latest Release of its Barrier-Breaking Lab Integration Platform

    Apr 25, 2022, 17:19 PM by
    Full story
  • Rho Experts Share How Customized Data Visualization Platform Provides Sponsors Real-time Study Data to Inform Decisions

    Apr 25, 2022, 17:19 PM by
    Rho Experts Share How Customized Data Visualization Platform Provides Sponsors Real-time Study Data to Inform Decisions Global CRO to demonstrate how data visualization can improve the conduct of clinical trials in a free webinar WHAT: Rho, a global full-service contract research organization (CRO) with a proven track record of drug development success, will discuss how ongoing access to real-time clinical study data and metrics is essential for efficient start-up and conduct of clinical trials in an upcoming webinar, “Using Advanced Data Visualization to Power Up Clinical Trials.” The webinar will take place on Wednesday, April 27, from 2-3 p.m. EST.
    Full story
  • Kyruus and Hyro Form Partnership to Help Healthcare Organizations Boost Online Conversion through Digital Self-Service

    Apr 25, 2022, 17:19 PM by
    Partnership will Enable Healthcare Organizations to Enhance Conversational AI Experiences with Robust Provider Search and Scheduling Capabilities
    Full story
  • Kyruus and Upfront Partner to Enable Healthcare Organizations to Maximize Digital Patient Acquisition and Retention

    Apr 25, 2022, 17:19 PM by
    Partnership Offers Consumer-Centric Search and Scheduling Options While Closing Gaps in Care through Personalized Digital Outreach to Patients
    Full story
  • Exogene raises $2 million for its AI platform to discover cell therapies for cancer

    Apr 25, 2022, 17:19 PM by
    Exogene, a biotech company discovering novel T-cell receptor-based cell therapies, today announces that it has raised US$2 million in funding to develop its artificial intelligence (AI) platform for T-cell receptor discovery.
    Full story
  • Creative Enzymes to Exhibit at the PEGS Boston Summit on May 2-6, 2022

    Apr 25, 2022, 17:19 PM by
    Full story
  • NorthX Biologics signs GMP manufacturing collaboration agreement with Abera Bioscience

    Apr 25, 2022, 17:19 PM by
    Sweden-based NorthX Biologics (“NorthX”), which focuses on process development and large-scale production of advanced biological drugs, has signed a collaboration agreement with Abera Bioscience (“Abera”) for upscaling and GMP manufacturing of its vaccine candidate against pneumococcus, Ab-01.12.
    Full story
  • PacBio Announces ML Methylation Calling, New Software, Consumables

    Apr 21, 2022, 14:46 PM by User Not Found
    Bio-IT World | Pacific Biosciences announced broad updates to its Sequel IIe and Sequel II Systems today including new capabilities in DNA methylation detection and workflow improvements promising a 50% decrease in NGS sequencing workflow and a 40% decrease in needed sample.
    Full story
  • Stanford: ‘Clinical Grade’ Long-Read Genome Sequencing Is Here

    Apr 20, 2022, 01:00 AM by User Not Found
    Bio-IT World | A Stanford team led by Euan Ashley, professor of medicine, genetics and biomedical data science, sequenced a patient’s genome in a snappy five hours and two minutes on a PromethION platform from Oxford Nanopore, an achievement ratified by the Genome in a Bottle Consortium of the National Institute of Science and Technology.
    Full story
  • «
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140 (current)
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy